NSEShareholders meeting26 Jun 2026 · 26 Jun 2026, 07:20 pm

Shareholders meeting

Sanofi Consumer Healthcare India Limited · SANOFICONR

✦ AI SummaryResults

Sanofi Consumer Healthcare India Limited has held its 3rd Annual General Meeting (AGM) on June 26, 2026, through video conferencing. The meeting was attended by members, directors, auditors, and other participants. The AGM transacted several items of business, including the adoption of annual audited financial statements, declaration of a final dividend, re-appointment of a director, and appointment of statutory auditors.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on June 26, 2026

Attachments (1)

📄

SANOFICONSUMER_26062026191934_AGM_Proceedings_s.pdf

pdf

Download →
View document text
26th June 2026 The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, C-1, Block G, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Mumbai - 400 001 Bandra East, Mumbai - 400 051 Scrip Code: 544250 Symbol: SANOFICONR Sub.: Summary of Proceedings of the 3rd Annual General Meeting Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of the 3rd Annual General Meeting of the Company held today i.e., Friday, 26th June 2026 from 3:00 P.M. (IST) onwards, through Video Conferencing / Other Audio Visual Means facility. Kindly take the same on records. Thanking You. Yours faithfully For Sanofi Consumer Healthcare India Limited Nikunjkumar Savaliya Company Secretary and Compliance Officer Membership No.: F7048 Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079 Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com Summary of Proceedings of the 3rd Annual General Meeting The Company Secretary welcomed the Members to the 3rd Annual General Meeting ("AGM") of the Company, held on Friday, 26th June 2026, through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"), in compliance with the applicable provisions of the Companies Act, 2013, the rules made thereunder, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the circulars issued by the Ministry of Corporate Affairs and SEBI from time to time. The Meeting commenced at 3:00 p.m. (IST). The Company Secretary informed the Members that the Company had provided the facility of remote e-voting to all Members holding shares as on the cut-off date, i.e., 19th June 2026, in respect of the businesses set out in the Notice convening the AGM. The remote e-voting facility remained open from 9:00 a.m. (IST) on Tuesday, 23rd June 2026 until 5:00 p.m. (IST) on Thursday, 25th June 2026. Members who had not cast their votes through remote e-voting were provided the facility to vote electronically during the AGM. He further informed the Members that Mr. Omkar Dindorkar (ACS 43029), Partner, or failing him, Ms. Deepti Kulkarni (ACS 34722), Partner, M/s. MMJB & Associates LLP, Practising Company Secretaries, had been appointed as the Scrutinizer to scrutinize the remote e-voting process and e-voting during the AGM in a fair and transparent manner. He further informed the Members that the combined voting results of the remote e-voting and e-voting conducted during the AGM, together with the Scrutinizer's Report, would be submitted to the Stock Exchanges and uploaded on the website of the Company within the prescribed timelines. Mr. Amit Jain, Chairman of the Company, chaired the proceedings of the Meeting. After ascertaining that the requisite quorum was present, he called the Meeting to order and welcomed the Members, Directors, Auditors and other participants attending the AGM. The Chairman informed the Members that Ms. Carol-Ann Stewart, Non-Executive Director, was unable to attend the Meeting due to unavoidable travel commitments. The Members were informed that the statutory registers and other documents referred to in the Notice convening the AGM were available for inspection upon request. The Notice convening the AGM was taken as read. The Chairman further informed the Members that the Reports of the Statutory Auditors and the Secretarial Auditors did not contain any qualifications, reservations, adverse remarks and accordingly, the same were also taken as read. The Chairman then addressed the Members and highlighted the Company's performance and developments during the financial year 2025. Thereafter, at the request of the Chairman, Mr. Himanshu Bakshi, Managing Director, addressed the Members and shared an overview of the Company's business performance, strategic initiatives and key developments. Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079 Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com The Chairman then proceeded with the business of the Meeting and informed the Members that the resolutions set out in the Notice dated 25th May 2026 convening the AGM had been put to vote through remote e-voting and e-voting during the AGM. The following items of business, as set out in the Notice convening the AGM, were transacted: Item No. Details of the Agenda items Resolution Type Ordinary Business 1. To receive, consider and adopt the Annual Audited Ordinary Standalone Financial Statements of the Company for the year ended 31st December 2025, including the Balance Sheet as on 31st December 2025, the Statement of Profit and Loss and the Cash Flow Statement for the Financial Year ended on that date and Reports of Board of Directors and Auditors thereon. 2. To declare a final dividend of Rs. 75 per equity share of O rdinary Rs. 10 each for the Financial Year ended 31st December 2025. 3. To re-appoint Mr. Stanislas Camart, (DIN: 10686945) as Ordinary Director, who retires by rotation and being eligible, offers himself for re-appointment. 4. Appointment of M/s. Price Waterhouse & Co Chartered Ordinary Accountants LLP (Firm Registration No.: 304026E/ E300009) as the Statutory Auditors of the Company Special Business 5. Appointment of M/s. Price Waterhouse & Co Chartered Ordinary Accountants LLP (Firm Registration No.: 304026E/E300009) as the Statutory Auditors of the Company to fill the casual vacancy 6. Ratification of remuneration to Cost Auditors Ordinary Thereafter, the Chairman opened the Question & Answer session for the registered speaker shareholders. 12 speaker shareholders participated in the discussion and sought clarifications on the financial performance, operations and other matters relating to the Company. The Chairman and the Management duly addressed the queries raised and suggestions made by the shareholders during the AGM. The Chairman informed the Members that the e-voting facility would remain available for 30 minutes after the conclusion of the AGM to enable those Members who had not exercised their voting rights through remote e-voting to cast their votes electronically. Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079 Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com Thereafter, the Chairman formally concluded the proceedings of the AGM by expressing his sincere appreciation to the Members for their continued trust, support and active participation. He also acknowledged the valuable contributions of the Board of Directors, employees and other stakeholders towards the Company's growth and success. The Chairman extended his best wishes to all present and thanked them for attending the Meeting. The Annual General Meeting concluded at 5:10 p.m. (IST) Kindly take the above information on record. Thanking You. Yours faithfully For Sanofi Consumer Healthcare India Limited Nikunjkumar Savaliya Company Secretary and Compliance Officer Membership No.: F7048 Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079 Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com